Medicenna Therapeutics Corp.

NASDAQ:MDNA

0.157 (USD) • At close November 14, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Omzet 0000000000000000000000000000000000
Kosten van de omzet 0000000000000000000000000000000000
Brutowinst 0000000000000000000000000000000000
Brutowinstmarge 0000000000000000000000000000000000
Onderzoek- en ontwikkelingskosten 3.1342.8121.5862.9452.3622.4111.1912.9076.2694.3493.7013.182.1761.8132.1351.6591.2460.8280.6611.2760.4460.6350.8641.3521.071.8052.0451.5980000.00100
Algemene en administratieve kosten 2.3021.6461.3841.9741.7171.9191.9291.981.9541.8571.9692.0931.6910.7220.5250.7410.6410.5860.5290.5630.5110.5610.5851.0020.7970.6122.4760.620.0060.0110.00900.1570
Verkoop- en marketingkosten 0000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2.3021.6461.3841.9741.7171.9191.9291.981.9541.8571.9692.0931.6910.7220.5250.7410.6410.5860.5290.5630.5110.5610.5851.0020.7970.6122.4760.620.0060.0110.00900.1570.015
Overige kosten 000.0010.0020.00200000000000000000000000-0.0110-0.007000
Bedrijfskosten 5.4374.4592.9714.9214.0814.333.1274.8978.2336.2165.715.2733.8672.5452.6652.4011.8891.291.0751.7130.8891.051.3042.1761.7022.2434.3712.2210.0060.0110.0090.0010.1570.015
Bedrijfsresultaat -6.809-5.71-1.704-8.36-7.104-4.475-3.039-4.971-8.267-6.023-5.579-5.162-3.853-2.593-2.634-2.413-1.873-1.285-1.102-1.703-0.881-1.061-1.298-2.17-1.685-2.228-4.35-2.214-0.006-0.011-0.009-0.001-0.157-0.015
Bedrijfsresultaat ratio 0000000000000000000000000000000000
Totaal overige inkomsten en kosten netto 3.0861.597-1.5373.783.8370.175-0.0790.090.055-0.17-0.104-0.0650.0810.193-0.0240.012-0.015-0.0050.026-0.01-0.0080.011-0.006-0.005-0.016-0.013-1.7690.042-0.0110-0.0070.5650.0720
Inkomen voor belasting -3.723-2.862-3.856-1.141-0.896-4.155-3.206-4.807-8.178-6.386-5.814-5.338-3.786-2.352-2.689-2.389-1.904-1.295-1.049-1.723-0.898-1.038-1.311-2.181-1.718-2.256-4.356-2.179-0.017-0.011-0.016-0.001-0.157-0.015
Inkomen voor belasting ratio 0000000000000000000000000000000000
Belastingkosten 0-1.5972.1520.340.162-0.1750.079-0.09-0.0550.170.1040.065-0.081-0.1940.024-0.0120.0150.005-0.0260.010.008-0.0110.0060.0050.0160.01300000000
Nettowinst -3.723-2.862-6.008-1.481-1.058-4.155-3.206-4.807-8.178-6.386-5.814-5.338-3.786-2.352-2.689-2.389-1.904-1.295-1.049-1.723-0.898-1.038-1.311-2.181-1.718-2.256-4.356-2.179-0.017-0.011-0.016-0.001-0.157-0.015
Nettowinstmarge 0000000000000000000000000000000000
WPA (Winst Per Aandeel) -0.054-0.041-0.086-0.021-0.017-0.074-0.058-0.089-0.15-0.12-0.11-0.11-0.078-0.049-0.073-0.072-0.066-0.045-0.037-0.069-0.037-0.042-0.054-0.09-0.071-0.093-0.18-1.88-0.047-0.03-0.044-0.035-0.47-0.014
Verwaterde WPA -0.054-0.041-0.086-0.021-0.017-0.074-0.058-0.089-0.15-0.12-0.11-0.11-0.078-0.049-0.073-0.072-0.066-0.045-0.037-0.069-0.037-0.042-0.054-0.09-0.071-0.093-0.18-1.88-0.047-0.03-0.044-0.035-0.47-0.014
EBITDA -6.808-5.709-1.703-4.92-4.732-4.321-3.119-4.961-8.257-6.013-5.568-5.152-3.844-2.583-2.63-2.412-1.872-1.284-1.074-1.701-0.879-1.059-1.297-2.168-1.683-2.223-4.349-2.212-0.006-0.011-0.009-0.566-0.157-0.015
EBITDA ratio 0000000000000000000000000000000000